Dermagen Ab

Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis

Older News

LUND, Sweden, December 2 - DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - today announced that Dermagen AB has received promising results from a clinical Phase I/IIa study.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy